Future Pharma Connect 2027 conference

The way pharma chooses and manages its outsourcing partners is changing. China+1 and the BIOSECURE Act are moving work to India, capacity for GLP-1s, peptides and sterile injectables is tight, and buyers expect partners to deliver quality, speed and transparency at the same time.

The two-day programme follows the life of a partnership.

Day 1, Select & Structure, covers partner selection, commercial models and China+1 sourcing. Day 2, Deliver & Scale, covers tech transfer, quality, capacity, startups and long-term governance.

Through keynotes, Leaders in Dialogue sessions, fireside chats, panels, workshops, a live debate, a startup pitch session and closed-door roundtables, the programme puts the buyer and partner view of each issue side by side.

Conference attendees with badges networking over coffee

What's on the programme

  • Leadership keynotes

    Senior leaders set the scene on the future of pharma outsourcing in India, how pharma evaluates CROs, CDMOs and CMOs, and getting tech transfer right first time.

  • Leaders in Dialogue

    A buyer and a partner discuss the same issue side by side, including whether an integrated CRDMO or best-of-breed specialists deliver better results.

  • Fireside chats

    Candid one-to-one conversations, including a pharma general counsel on protecting IP and confidentiality in outsourced programmes.

  • Panel discussions

    Viksit Bharat 2047, co-development deals and pricing pressure, second sourcing and key starting materials, joint FDA inspection readiness, and capacity for GLP-1s, sterile fill-finish and biologics.

  • Workshops

    Build a partner scorecard, negotiate a risk-sharing contract or plan a second-source qualification, and leave with a working template.

  • The Great Debate

    “KPIs Are Killing Partnerships”: two teams argue for and against, and the audience votes before and after.

  • Startup pitch session

    Four startups from AI drug discovery, clinical trial technology, smart manufacturing and quality technology pitch to a jury of pharma buyers, CDMO leaders and investors. Each gets 10 minutes (a 7-minute pitch and 3 minutes of jury questions) and competes for the jury score and the audience vote. The pitching startups also exhibit in the Startup Zone.

  • Closed-door roundtables

    Six invitation-only discussions of 10–12 senior leaders under the Chatham House Rule, three on each day, for procurement, CDMO, supply chain, quality, biotech and alliance leaders.

  • Networking and B2B meetings

    Pre-booked one-to-one meetings in the meeting lounge during every break, plus expo networking and the Future Pharma Connect Awards evening.

The agenda, day by day

Both days: registration and networking breakfast 09:00–10:00, conference 10:00–17:00.

Day 1 | Tuesday, 27 April 2027

Select & Structure

  1. Opening Keynote: From Vendor to Value Partner: The Future of Pharma Outsourcing in India
  2. Headline Partner Presentation: India's Pharma Outsourcing Opportunity
  3. Panel: Can India's Pharma Industry Deliver on the Viksit Bharat 2047 Vision?
  4. Block 1: Choosing the Right Partner
  5. Block 2: Commercial and Contract Models
  6. Block 3: China+1 and the BIOSECURE Act in Practice
  7. Interactive Workshops and Closed-Door Roundtables (in parallel), 16:15–17:00
  8. Expo Networking, 17:00–17:30
  9. Future Pharma Connect Awards & Networking Dinner, from 17:30

Day 2 | Wednesday, 28 April 2027

Deliver & Scale

  1. Block 4: Molecule to Market
  2. Block 5: Quality Agreements and Inspection Readiness
  3. Block 6: Capacity for High-Demand Products
  4. Startup Pitch Session: Four Startups Shaping the Future of Pharma Outsourcing
  5. Block 7: Partnership Governance and Performance, including The Great Debate
  6. Closed-Door Roundtables, 16:20–17:00
  7. Close of Summit and Expo, 17:00
Download the full agenda

Programme timings and session details are subject to final confirmation.

What you get as a delegate

  • Strategic business partnerships

    Meet pharma and biotech companies, CROs, CDMOs, CMOs and solution providers through pre-booked one-to-one meetings.

  • Buyer-led insights

    Hear directly how pharma evaluates partners, structures deals and decides when to switch.

  • Practical partnership discussions

    Tackle tech transfer, handover failures, quality agreements, second sourcing and capacity constraints with peers facing the same issues.

  • China+1 opportunities

    Understand which work is moving to India under the BIOSECURE Act and how to qualify for it.

  • Three months of follow-up support

    Follow-up support on your questions is guaranteed for three months after the event.

  • Where outsourcing is heading by 2030

    See where new commercial models, integrated CRDMOs and startup innovation are taking pharma outsourcing through 2030.

Who should attend

CEOs, managing directors, CXOs, presidents, vice presidents, directors, general managers, department heads and senior managers from pharma and biotech companies, CROs, CDMOs, CMOs and solution providers, working across:

  • Outsourcing and sourcing
  • Manufacturing and operations
  • Quality and regulatory
  • Research, development and clinical
  • Pharma services
  • Business and commercial
  • Technology and innovation

Choose your pass

Conference delegate

Both conference days, workshops, expo floor, Expo Theatre, meals and networking.

VIP delegate

Everything in the delegate pass, plus 3 pre-scheduled B2B meetings, your logo on the VIP partner wall, an interview feature and the awards dinner.

Expo visitor

Free

For pre-registered trade visitors: expo floor, Expo Theatre and expo networking. Conference sessions are not included.

Enquire about group registrations

Join the discussion in Hyderabad

Bring your experience, meet your next partner and join two days of buyer-led sessions.